Core Points - Shenzhen Yahui Long Biotechnology Co., Ltd. has received a medical device registration certificate from the Guangdong Provincial Drug Administration, marking a significant milestone for the company [1][2]. Group 1: Medical Device Registration - The registered product is an automatic fluorescence immunoassay analyzer, capable of quantitative or qualitative detection of analytes in human serum and plasma samples [1]. - The analyzer has a maximum processing capacity of 72 samples per hour and can simultaneously test multiple different biomolecules, allowing for multiplex testing [1]. Group 2: Market Impact - The acquisition of the registration certificate represents a breakthrough for the company in the field of multiplex detection, enhancing its core competitiveness and market expansion capabilities [2]. - The liquid phase multiplex detection platform, which is being applied in the field of autoantibody detection, reflects the company's innovative spirit and commitment to advancing autoantibody testing in China [2].
证券代码：688575 证券简称：亚辉龙 公告编号：2025-062